Beximco Pharma gets license for oral anti-Covid drug
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 29, 2022
SUNDAY, MAY 29, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Beximco Pharma gets license for oral anti-Covid drug

Covid-19 in Bangladesh

TBS Report
20 January, 2022, 02:40 pm
Last modified: 20 January, 2022, 06:05 pm

Related News

  • Beximco continues profit growth momentum  
  • Beximco to produce Pfizer’s Covid-19 drug locally 
  • DGDA orders to test a batch of Napa syrup
  • Janata Bank recognises Beximco as ‘best customer’
  • Vaccine sales boost Beximco Pharma’s profit

Beximco Pharma gets license for oral anti-Covid drug

The company is expected to start domestic distribution and export from the end of 2022

TBS Report
20 January, 2022, 02:40 pm
Last modified: 20 January, 2022, 06:05 pm
Photo: Courtesy
Photo: Courtesy

Beximco Pharmaceuticals Limited has become the first Bangladeshi company to get permission to produce "molnupiravir," an oral drug for the treatment of Covid-19.

The United Nations-backed Medicines Patent Pool (MPP) granted a sub-license to Beximco Pharma for the local production of the oral drug originally developed by MSD, a trade name of Merck and Co Inc.

The partnership with Beximco was announced after the MPP expanded its network of partnered generic manufacturers, said a press release on Thursday.

The sub-license agreement is a result of the voluntary licensing agreement signed by the MPP and MSD in October 2021 to facilitate affordable global access for molnupiravir, which MSD is developing in partnership with Ridgeback Biotherapeutics.

Under this agreement, MPP may sub-license the production of the drug to global generic drug manufacturers to ensure a steady supply in different regions of the world. 

Molnupiravir is an oral antiviral to treat symptomatic Covid-19, which received conditional marketing authorisation in the UK from the UK Medicines and Healthcare Regulatory Agency on 4 November and received emergency use authorisation in the US from the US Food and Drug Administration on 23 December last year.

Beximco Pharma will manufacture molnupiravir in Bangladesh and is expected to start domestic distribution and export from the end of 2022, following successful technology transfer and manufacturing regulatory approvals under the license from MPP.

The company will continue to sell its own generic version of molnupiravir (Emorivir), as announced on 9 November 2021, under the World Trade Organization's Least Developed Country (LDC) waiver in the meantime.

Top News

Molnupiravir / Beximco / Beximco Pharmaceuticals / Beximco Pharma / Covid oral drug

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Patients opting to delay crucial treatment amid rising costs
    Patients opting to delay crucial treatment amid rising costs
  • Bankers unhappy with uniform exchange rate
    Bankers unhappy with uniform exchange rate
  • Photo: PID
    Brand Bangladesh as powerful peace promoting country: PM

MOST VIEWED

  • 28 new Covid cases reported in a day
    28 new Covid cases reported in a day
  • 23 new Covid cases reported in a day
    23 new Covid cases reported in a day
  • Illustration: Collected
    Bangladesh reports 28 new Covid cases in 24hrs
  • Illustration: Collected
    Bangladesh logs 30 new Covid cases in 24hrs
  • Illustration: Collected
    34 Covid cases reported in 24 hours
  • 2 deaths from Covid-19 logged after a month
    2 deaths from Covid-19 logged after a month

Related News

  • Beximco continues profit growth momentum  
  • Beximco to produce Pfizer’s Covid-19 drug locally 
  • DGDA orders to test a batch of Napa syrup
  • Janata Bank recognises Beximco as ‘best customer’
  • Vaccine sales boost Beximco Pharma’s profit

Features

Aiman R Khan. Illustration: TBS

Why ‘marry your rapist’ court orders are not always what they seem

1h | Thoughts
Photo: Collected

Top 3 The Ordinary products that give extraordinary results

3h | Mode
Photo: Courtesy

KVN Beauty: Channel your inner Bangalee baddie

3h | Mode
CholPori is planning to roll out their platform in schools so teachers can utilise their tools for the classroom. Photo: Courtesy

CholPori: Where learning is practical, fun and inclusive

3h | Panorama

More Videos from TBS

Photo: TBS

Tips to help you become a successful lawyer

4h | Videos
People bid adieu to Abdul Gaffar Chowdhury

People bid adieu to Abdul Gaffar Chowdhury

4h | Videos
Photo: TBS

Harassment over 'indecent clothing': Women gather at Narsingdi railway station to protest, show solidarity

4h | Videos
Attorney General's suggestion to reduce case clutter

Attorney General's suggestion to reduce case clutter

18h | Videos

Most Read

1
Bangladesh Bank GM, DGM’s designation changed
Banking

Bangladesh Bank GM, DGM’s designation changed

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

5
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab